Cardiac Rhythm Management Market Research Report by Product (CRTs, Defibrillators, and Pacemaker), by End-User (Ambulatory Surgical Centers (ASCs), Home Settings, and Hospitals & Clinics), by State (California, Florida, and Illinois) - United States Forec

Cardiac Rhythm Management Market Research Report by Product (CRTs, Defibrillators, and Pacemaker), by End-User (Ambulatory Surgical Centers (ASCs), Home Settings, and Hospitals & Clinics), by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19

The United States Cardiac Rhythm Management Market size was estimated at USD 3,206.71 million in 2020 and expected to reach USD 3,651.25 million in 2021, at a CAGR 11.10% to reach USD 6,031.16 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Cardiac Rhythm Management to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across CRTs, Defibrillators, and Pacemaker. The CRTs is further studied across CRT Pacemaker and CRT- Defibrillators. The Defibrillators is further studied across ICDs, s-ICD, and T-ICD. The Pacemaker is further studied across External Pacemaker and Implantable Pacemaker. The External Pacemaker is further studied across Automatic External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators.

Based on End-User, the market was studied across Ambulatory Surgical Centers (ASCs), Home Settings, and Hospitals & Clinics.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiac Rhythm Management Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cardiac Rhythm Management Market, including Abbott Laboratories Inc, ABIOMED Inc, Bayer AG, Biotronik AG, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Novartis AG, Pfizer Inc, Sanofi SA, Schiller AG, and Stryker Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Cardiac Rhythm Management Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Cardiac Rhythm Management Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Cardiac Rhythm Management Market?
4. What is the competitive strategic window for opportunities in the United States Cardiac Rhythm Management Market?
5. What are the technology trends and regulatory frameworks in the United States Cardiac Rhythm Management Market?
6. What is the market share of the leading vendors in the United States Cardiac Rhythm Management Market?
7. What modes and strategic moves are considered suitable for entering the United States Cardiac Rhythm Management Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Cardiac Rhythm Management Market, by Product
6.1. Introduction
6.2. CRTs
6.2.1. CRT Pacemaker
6.2.2. CRT- Defibrillators
6.3. Defibrillators
6.3.1. ICDs
6.3.2. s-ICD
6.3.3. T-ICD
6.4. Pacemaker
6.4.1. External Pacemaker
6.4.1.1. Automatic External Defibrillators
6.4.1.2. Manual External Defibrillators
6.4.1.3. Wearable Cardioverter Defibrillators
6.4.2. Implantable Pacemaker
7. Cardiac Rhythm Management Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgical Centers (ASCs)
7.3. Home Settings
7.4. Hospitals & Clinics
8. California Cardiac Rhythm Management Market
9. Florida Cardiac Rhythm Management Market
10. Illinois Cardiac Rhythm Management Market
11. New York Cardiac Rhythm Management Market
12. Ohio Cardiac Rhythm Management Market
13. Pennsylvania Cardiac Rhythm Management Market
14. Texas Cardiac Rhythm Management Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbott Laboratories Inc
16.2. ABIOMED Inc
16.3. Bayer AG
16.4. Biotronik AG
16.5. Boston Scientific Corporation
16.6. Koninklijke Philips N.V.
16.7. LivaNova PLC
16.8. Medtronic PLC
16.9. Novartis AG
16.10. Pfizer Inc
16.11. Sanofi SA
16.12. Schiller AG
16.13. Stryker Corporation
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRTS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRT PACEMAKER, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRT PACEMAKER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRT- DEFIBRILLATORS, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRT- DEFIBRILLATORS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ICDS, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ICDS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY S-ICD, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY S-ICD, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY T-ICD, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY T-ICD, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL PACEMAKER, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL PACEMAKER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AUTOMATIC EXTERNAL DEFIBRILLATORS, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AUTOMATIC EXTERNAL DEFIBRILLATORS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE PACEMAKER, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE PACEMAKER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 34. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2026
FIGURE 36. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 38. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOME SETTINGS, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOME SETTINGS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 40. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2026 (USD MILLION)
FIGURE 41. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 42. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 43. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 44. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRT PACEMAKER, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CRT- DEFIBRILLATORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ICDS, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY S-ICD, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY T-ICD, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL PACEMAKER, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AUTOMATIC EXTERNAL DEFIBRILLATORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE PACEMAKER, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOME SETTINGS, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: SCORES
TABLE 23. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: BUSINESS STRATEGY
TABLE 24. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: PRODUCT SATISFACTION
TABLE 25. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: RANKING
TABLE 26. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 27. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: MERGER & ACQUISITION
TABLE 28. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 29. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 30. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: INVESTMENT & FUNDING
TABLE 31. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 32. UNITED STATES CARDIAC RHYTHM MANAGEMENT MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook